News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
366,733 Results
Type
Article (14841)
Company Profile (114)
Press Release (351778)
Multimedia
Podcasts (37)
Webinars (7)
Section
Business (112864)
Career Advice (466)
Deals (18630)
Drug Delivery (29)
Drug Development (31392)
Employer Resources (50)
FDA (8808)
Job Trends (7693)
News (173264)
Policy (12426)
Tag
Academia (1329)
Accelerated approval (3)
Allergies (42)
Alliances (34861)
ALS (26)
Alzheimer's disease (517)
Antibody-drug conjugate (ADC) (75)
Approvals (8842)
Artificial intelligence (247)
Autoimmune disease (4)
Automation (13)
Bankruptcy (131)
Best Places to Work (6534)
BIOSECURE Act (7)
Biosimilars (10)
Biotechnology (86)
Bladder cancer (31)
Brain cancer (13)
Breast cancer (119)
Cancer (1067)
Cardiovascular disease (68)
Career advice (413)
Career pathing (9)
CAR-T (107)
Cell therapy (277)
Cervical cancer (10)
Clinical research (24694)
Collaboration (613)
Compensation (114)
Complete response letters (3)
COVID-19 (1151)
CRISPR (39)
C-suite (149)
Cystic fibrosis (47)
Data (1025)
Decentralized trials (1)
Denatured (18)
Depression (16)
Diabetes (111)
Diagnostics (4923)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (77)
Drug pricing (14)
Drug shortages (4)
Duchenne muscular dystrophy (23)
Earnings (38893)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51640)
Executive appointments (415)
FDA (9475)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (485)
Gene editing (88)
Generative AI (24)
Gene therapy (176)
GLP-1 (224)
Government (1239)
Grass and pollen (2)
Guidances (34)
Healthcare (9907)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (30)
Indications (13)
Infectious disease (1227)
Inflammatory bowel disease (65)
Inflation Reduction Act (3)
Influenza (32)
Intellectual property (64)
Interviews (53)
IPO (8015)
IRA (8)
Job creations (1441)
Job search strategy (368)
Kidney cancer (4)
Labor market (10)
Layoffs (118)
Leadership (3)
Legal (2542)
Liver cancer (35)
Lung cancer (129)
Lymphoma (67)
Machine learning (5)
Management (17)
Manufacturing (187)
MASH (16)
Medical device (11507)
Medtech (11512)
Mergers & acquisitions (10972)
Metabolic disorders (223)
Multiple sclerosis (29)
NASH (3)
Neurodegenerative disease (31)
Neuropsychiatric disorders (4)
Neuroscience (717)
NextGen: Class of 2025 (3553)
Non-profit (1525)
Now hiring (9)
Obesity (91)
Opinion (78)
Ovarian cancer (39)
Pain (52)
Pancreatic cancer (41)
Parkinson's disease (69)
Partnered (12)
Patents (150)
Patient recruitment (58)
Peanut (26)
People (32858)
Pharmaceutical (16)
Phase I (9113)
Phase II (11141)
Phase III (7207)
Pipeline (589)
Policy (30)
Postmarket research (504)
Preclinical (4141)
Press Release (66)
Prostate cancer (45)
Psychedelics (4)
Radiopharmaceuticals (155)
Rare diseases (137)
Real estate (3373)
Recruiting (20)
Regulatory (9449)
Reports (18)
Research institute (1274)
Resumes & cover letters (70)
Rett syndrome (4)
RNA editing (2)
RSV (23)
Schizophrenia (13)
Series A (89)
Series B (53)
Service/supplier (7)
Sickle cell disease (18)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2510)
State (2)
Stomach cancer (2)
Supply chain (27)
Tariffs (4)
The Weekly (18)
Vaccines (324)
Venture capitalists (19)
Weight loss (35)
Women's health (17)
Worklife (2)
Date
Today (63)
Last 7 days (456)
Last 30 days (1355)
Last 365 days (17167)
2025 (5604)
2024 (18724)
2023 (22122)
2022 (30836)
2021 (32558)
2020 (30574)
2019 (25854)
2018 (19504)
2017 (18896)
2016 (17799)
2015 (20608)
2014 (15242)
2013 (12839)
2012 (13862)
2011 (14145)
2010 (12921)
Location
Africa (318)
Alabama (41)
Alaska (6)
Arizona (125)
Arkansas (10)
Asia (24141)
Australia (4202)
California (2997)
Canada (1065)
China (252)
Colorado (172)
Connecticut (131)
Delaware (46)
Europe (49402)
Florida (494)
Georgia (139)
Idaho (33)
Illinois (291)
India (13)
Indiana (163)
Iowa (5)
Japan (117)
Kansas (83)
Kentucky (7)
Louisiana (6)
Maine (20)
Maryland (462)
Massachusetts (2081)
Michigan (187)
Minnesota (254)
Mississippi (2)
Missouri (62)
Montana (24)
Nebraska (15)
Nevada (23)
New Hampshire (67)
New Jersey (929)
New Mexico (16)
New York (878)
North Carolina (537)
North Dakota (8)
Northern California (1128)
Ohio (104)
Oklahoma (11)
Oregon (20)
Pennsylvania (610)
Puerto Rico (10)
Rhode Island (25)
South America (509)
South Carolina (21)
South Dakota (1)
Southern California (1230)
Tennessee (62)
Texas (476)
United States (11850)
Utah (108)
Virginia (59)
Washington D.C. (12)
Washington State (348)
West Virginia (3)
Wisconsin (39)
366,733 Results for "stemcell technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
STEMCELL Technologies Announces Acquisition of Propagenix Inc.
STEMCELL Technologies is pleased to announce the acquisition of Propagenix Inc.
January 19, 2024
·
3 min read
Press Releases
Applied StemCell Announces Drug Master File Submission to the US FDA for their GMP-Grade iPSC Cell Line
April 14, 2025
·
2 min read
STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company
STEMCELL Technologies is pleased to announce the acquisition of substantially all assets of SQZ Biotechnologies Company —a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them rather than using electricity.
February 29, 2024
·
3 min read
STEMCELL Technologies Releases “Toward Sustainable Science” Report
STEMCELL Technologies, Canada’s largest biotechnology company, is releasing its first annual sustainability report today.
October 11, 2023
·
3 min read
STEMCELL Technologies Wins a Canada’s Most Admired Corporate Cultures™ of 2023 Award
STEMCELL Technologies, Canada’s largest biotechnology company, has received the Canada’s Most Admired Corporate Cultures™ of 2023 award by Waterstone Human Capital.
November 24, 2023
·
3 min read
STEMCELL Technologies Expands into Toronto’s MaRS Centre, Grows North American Presence
STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the opening of its new Canadian sales office at the MaRS Centre in downtown Toronto, Ontario.
October 26, 2023
·
3 min read
STEMCELL Technologies Announces FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit to Support Cancer Diagnostic Tests
STEMCELL Technologies is pleased to announce that its new EasySep™ Human Bone Marrow CD138 Positive Selection Kit has been granted de novo classification by the U.S. Food and Drug Administration (FDA) as a first-of-its-kind in vitro diagnostic (IVD) medical device for hematopoietic cell enrichment.
March 26, 2024
·
4 min read
STEMCELL Technologies Partners with Science World to Empower Girls Pursuing Science-related Careers
STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce it will be the presenting partner of the Girls and STEAM Summit at Science World in Vancouver.
September 25, 2023
·
3 min read
STEMCELL Technologies Celebrates 30 Years With Unprecedented Annual Growth
STEMCELL Technologies, Canada’s largest biotechnology company, is marking its 30th year of accelerating research into cancer and other diseases by celebrating its culture of collaboration, curiosity, and discovery.
July 12, 2023
·
4 min read
Deals
QHP Capital Acquires Applied StemCell
QHP Capital, announced its acquisition of Applied StemCell, Inc., a leading cell and gene therapy CRO/CDMO focused on supporting the research community and biotechnology industry in developing and manufacturing cell and gene products.
October 9, 2023
·
4 min read
1 of 36,674
Next
